Company Overview
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer.
This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts
Summary
Reporting to the CHRO, the Director, Human Resources Business Partner (HRBP) provides HR leadership and consultation to client groups within one or multiple functions, including Clinical Development, Regulatory, and other key late-stage clinical areas. The HRBP is a trusted advisor to leaders, providing expert HR advice and advanced solutions that enable the achievement of business strategies by leveraging a significant understanding of the operating environment. This role drives talent management and helps architect and manage organizational change. The role is responsible for the delivery of HR programs and services such as talent/career development, manager coaching and consultation, employee relations, and performance management.
Your role
- Provides strategic HR leadership and expert guidance to assigned client groups, along with consultation and delivery of HR programs and services to achieve key business objectives
- Leverages previous experience and data to provide critical insights into business and talent trends that inform the overall business and HR priorities. Provides insights in a simple, creative, and relevant way that challenges current thinking, informs business decisions, and shows how decisions impact business outcomes
- Proactively defines, builds, and implements value-added HR strategies and solutions
- Advises functional leaders in solving complex issues related to organization design, development, and change leadership
- Establishes strategies and tactics to enable the business to attract, develop, and retain high-quality talent at all levels to support the growth objectives, opportunities, and strategies of the business
- Leads the strategic workforce planning efforts to ensure the people and talent strategy is in alignment with the organization's long range strategic plan (identification of long-term capability needs, talent acquisition and succession planning)
- Builds strong partnerships within the HR team to enhance the function’s effectiveness in providing solutions to key business needs and to roll out corporate-wide programs that enhance the overall employee experience and support growth and success of overall business strategy
- Works with clients to implement and manage key HR processes, such as year-end performance management (performance assessment, calibration, and compensation planning)
- Partners with Talent Acquisition (TA) to ensure TA strategy is in place to deliver on key hires and growth plans
What you bring
Education and Experience:
- Undergraduate degree in human resources or related, relevant discipline
- Typically requires 10 years of experience or the equivalent combination of education and experience
Knowledge and Skills:
- Experience developing and implementing HR strategies
- Track record of developing strategic workforce plans, from conception to implementation
- Highly experienced in talent management, succession planning, and career growth and development
- Strong experience managing and/or leading culture and change management or organizational effectiveness initiatives
- Experience and expert understanding of management development, employee relations, data and analytics
Traits and Qualities:
- Ability to influence positively including in situations without direct authority
- Ability to work independently and collaboratively, in a matrix team environment consisting of internal and external team members
- Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines
- Excellent planning, organization and time management skills including the ability to support, prioritize, and multi-task
- Highly collaborative team player who fosters open communication and develops important relationships with key stakeholders
- Outstanding interpersonal and communication abilities with a high degree of emotional intelligence
- Possess the ability, business maturity and interpersonal savvy to be proactive and establish credibility with all employees across the Company
- Have proven communication skills, both written and verbal, and the ability to present information clearly to a variety of audiences
- Able to learn quickly and take a project from idea to execution (strategy to operational) quickly and independently
- Thrives in high energy and fast paced organization with ongoing simultaneous initiatives
- Builds consensus and alignment and persuades others to take action
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
#LI-Onsite
What We Do
Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. Tango was launched in 2017 with a $55 million Series A investment from Third Rock Ventures. The company has established a robust product engine that leverages advances in DNA sequencing and CRISPR-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. Tango Therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. These include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. What fuels each of Tango’s programs is an increasingly sophisticated ability to utilize synthetic lethality - the interaction between two genes that causes cell death when both are inactivated. In cancer cells, one of these genes is inactivated by mutation; the other will be inactivated by a drug. This approach leaves normal cells largely unaffected, with the potential to greatly enhance anti-tumor efficacy and reduce associated toxicity. Tango’s success will be driven by its depth of understanding of the genetic subtypes of cancer, and corresponding insights into novel drug targets and combinations uniquely relevant to each subtype. By shaping discovery efforts in this way, Tango has the potential to reach the clinic quickly, and with a clear plan for identifying the patients most likely to benefit from each new treatment, an approach that could increase both speed and probability of success in translating novel target discoveries into transformational new medicines for patients.
